Red nose: primary cutaneous marginal zone B-cell lymphoma

Leuk Res. 2010 May;34(5):682-4. doi: 10.1016/j.leukres.2009.10.024. Epub 2009 Nov 27.

Authors

Aristóteles Rosmaninho¹, Rosário Alves, Margarida Lima, Inês Lobo, Isabel Amorim, Manuela Selores

Affiliation

¹ Department of Dermatology, Centro Hospitalar do Porto-HSA, Oporto, Portugal. [email protected]

PMID: 19945162
DOI: 10.1016/j.leukres.2009.10.024

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Topical
Aged, 80 and over
Anti-Bacterial Agents / therapeutic use
Anti-Infective Agents / therapeutic use
Antineoplastic Agents / administration & dosage
Female
Humans
Immunohistochemistry
Interferon-gamma / administration & dosage
Lymphoma, B-Cell, Marginal Zone / drug therapy
Lymphoma, B-Cell, Marginal Zone / pathology*
Metronidazole / therapeutic use
Minocycline / therapeutic use
Nose / pathology*
Recombinant Proteins
Rosacea / complications
Rosacea / drug therapy
Skin Neoplasms / drug therapy
Skin Neoplasms / pathology*

Substances

Anti-Bacterial Agents
Anti-Infective Agents
Antineoplastic Agents
Recombinant Proteins
Metronidazole
Interferon-gamma
Minocycline